Beyond Meat is rolling out its steak substitute in grocery stores

Beyond Meat is rolling out its steak substitute in grocery stores


Beyond Steak

Source: Beyond Meat

Beyond Meat is launching a steak substitute in grocery stores on Monday.

The new product will roll out nationwide at more than 5,000 Kroger and Walmart stores, as well as Albertsons, Ahold Delhaize, Jewel-Osco, Sprouts and other local grocers.

The announcement concludes a rocky month for the maker of meat alternatives. Beyond ousted Chief Operating Officer Doug Ramsey after he was arrested for allegedly biting another man’s nose. The company also announced plans to cut 19% of its workforce, or roughly 200 employees, as well as the departure of its chief financial officer and the elimination of the chief growth officer role.

Amid the chaos, Beyond and Yum Brands’ Taco Bell started testing meatless carne asada using its Beyond Steak product at restaurants in Dayton, Ohio.

The Beyond Steak that will be sold in grocery stores comes packaged in bite-sized pieces. It uses faba bean protein as its base and contains 21 grams of protein per serving, according to the company. It also has lower saturated fat content than beef steak and contains no cholesterol. The 10-ounce package will retail for $7.99.

Historically, product launches have boosted Beyond’s sales, driving new and returning customers to try the item. That would be welcome news for the company, which has seen its sales slide and investors lose hope in its long-term growth prospects.

In the second quarter, Beyond reported U.S. grocery sales rose just 2.2% while restaurant revenue was off 2.4%. This year, shares of the company have lost 80% of their value, shrinking its market value to $821 million. At its record high in July 2019, Beyond was valued at $13.4 billion.

The pandemic shift to eating at home and loading up pantries benefited Beyond and other plant-based meat companies. But many shoppers didn’t stick with eating meat alternatives once the novelty wore off, and inflation has put pressure on budgets, making the more expensive substitutes even less attractive to consumers.

Not all Beyond launches have been a hit. Shoppers weren’t very keen on Beyond Meat Jerky, a meat-free jerky made through the company’s joint venture with PepsiCo. Executives said in August that demand was below its initial estimates. The snack item also has been very expensive for Beyond to produce, putting pressure on its profit margins this year, although that’s expected to wane.

Beyond is expected to report its third-quarter results after the bell on Nov. 9.

Beyond Meat stock continues to fall after COO's arrest for biting man's nose



Source

Sen. Warren blasts CFPB director for undermining Trump’s credit card affordability push
Business

Sen. Warren blasts CFPB director for undermining Trump’s credit card affordability push

U.S. Senator Elizabeth Warren (D-MA) and Director of the United States Office of Management and Budget, Russell Vought. Kevin Mohatt | Kevin Lamarque | | Reuters Sen. Elizabeth Warren on Friday accused the acting head of the Consumer Financial Protection Bureau of undermining President Donald Trump’s stated push to make credit cards more affordable, according […]

Read More
Why a niche category of CRE lending is suddenly seeing record deals
Business

Why a niche category of CRE lending is suddenly seeing record deals

Wepro | Moment | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight […]

Read More
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
Business

What obesity drugmakers see next in the market: More pills, easier access and drug combinations

A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey | Bloomberg | Getty Images The future of the booming obesity drug market won’t hinge on drugs that deliver greater weight loss alone.  Top executives from drugmakers big and small told CNBC that the next phase […]

Read More